Healthy Volunteers
Conditions
Sponsors
QUIRIS Healthcare GmbH & Co. KG
Eligibility
Sex/Gender
Female
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Written Informed Consent to participate in the study, Willingness to actively participate in the study and to come to the scheduled visits, Caucasian
Exclusion criteria
Exclusion criteria: Documented allergies to the food supplement product or its constituents, Conditions which exclude a participation or might influence the test reaction /Evaluation; Pregnancy or lactation; Drug addicts, alcoholics; AIDS, HIV-positive or infectious hepatitis if known to the subjects; Participation or being in the waiting period after participation in similar cosmetic and/or pharmaceutical studies; One of the following illnesses that might require regular systemic medication: Cancer; Diabetes; Active skin disease at the measurement area, Moles, tattoos, scars, irritated skin, etc. at the measurement area that could influence the Investigation; Systemic therapy with immuno-suppressive drugs (e.g. corticosteroids) and/or antihistamines (e.g. antiallergics) and/or antibiotics within the last 7 days prior to the start of the study and/or throughout the entire course of the study; Systemic therapy with anti-phlogistic agents or analgetics (e.g. diclophenac) (except for minor pain relief medicine, like acetylsalicylic acid or paracetamol) within the last 3 days prior to the start of the study and/or throughout the entire course of the study; Any topical medication at the measurement area within the last 3 days prior to the start of the study and/or throughout the entire course of the study; Intensive use of skin care products at the measurement area (more than one skin care product, use more than once per day) within one month prior to the start of the study; Intake of supplements containing vitamins, trace elements, isoflavones, herbal extracts, oils (fish oil or vegetal oil), polyphenols, phytoestrogens, or other active compounds which may have an effect on skin 3 months prior to the start of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of the Collagen structure of the facial Skin by confocal microscopy before and after 12 week intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Questionnaires regarding product properties, acceptance and tolerance at the final visit | — |
Countries
Germany
Contacts
Public ContactJan-Christoph Kattenstroth
QUIRIS Healthcare GmbH & Co. KG
Outcome results
None listed